Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported net income rose 61% to $7.8 billion while EPS increased 59% to $1.37. Adjusted EPS grew 72% to $1.62. Both the top and bottom line numbers beat estimates. For the full year of 2022, revenues […]
Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported net income rose 61% to $7.8 billion while EPS increased 59% to $1.37. Adjusted EPS grew 72% to $1.62. Both the top and bottom line numbers beat estimates. For the full year of 2022, revenues […]
Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today.
Total revenues increased 77% year-over-year to $25.7 billion.
Reported net income rose 61% to $7.8 billion while EPS increased 59% to $1.37. Adjusted EPS grew 72% to $1.62.
Both the top and bottom line numbers beat estimates.
For the full year of 2022, revenues are expected to range between $98-102 billion and adjusted EPS is estimated to be $6.25-6.45.
